menu
    • menu

    Company profile for Biocytogen

    Pfanstiehl, a global leader in the manufacture of cGMP high purity, low endotoxin, low metals (HPLE-LM)TM injectable grade excipients.

    Virtual Booth

    Contact Supplier

    Global Pharma Healthcare: Setting the global benchmark in quality, innovation, and care

    Virtual Booth

    Contact Supplier

    Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

    Virtual Booth

    Contact Supplier

    Phyton is a World Leader in Plant Cell Fermentation Technology and Commercial Manufacturing.

    Virtual Booth

    Contact Supplier

    Farmak works in the development, production and marketing of APIs, Intermediates & Specialties// FDA inspected.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Biocytogen Pharmaceuticals (Beijing) Co., Ltd. is a global biotechnology company that drives the research and development of novel antibody-based drugs with innovative technologies. Using its proprietary RenMab™/RenLite™ mice platforms for fully human monoclonal and bispecific antibody development, Biocytogen has integrated its in vivo drug efficacy screening platforms and strong clinical development expertise to streamlin...
    Biocytogen Pharmaceuticals (Beijing) Co., Ltd. is a global biotechnology company that drives the research and development of novel antibody-based drugs with innovative technologies. Using its proprietary RenMab™/RenLite™ mice platforms for fully human monoclonal and bispecific antibody development, Biocytogen has integrated its in vivo drug efficacy screening platforms and strong clinical development expertise to streamline the entire drug development process. Biocytogen is undertaking a large-scale project to develop antibody drugs for more than 1000 targets.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    BiocytogenChina Flag
    Country
    Country
    China
    Address
    Address
    12th floor of Beijing Yizhuang Biomedical Park.\n
    Telephone
    Telephone
    010-56315307
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://biocytogen.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Biocytogen's STAR IPO: As First 'H+A' Global Drug Developer
    Biocytogen's STAR IPO: As First 'H+A' Global Drug Developer

    10 Dec 2025

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2025-12-10/biocytogen-completes-star-market-ipo-becoming-the-first-hplusa-global-drug-innovator-1

    PHARMIWEB
    10 Dec 2025
    Share Share
    FDA Clears IND for Biocytogen's IDE034 Bispecific ADC
    FDA Clears IND for Biocytogen's IDE034 Bispecific ADC

    04 Dec 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251204253955/en/IDE034-a-Bispecific-ADC-Licensed-by-Biocytogen-to-IDEAYA-Receives-FDA-IND-Clearance

    BUSINESSWIRE
    04 Dec 2025
    Share Share
    Biocytogen & Tubulis Sign Exclusive License for Single Antibody
    Biocytogen & Tubulis Sign Exclusive License for Single Antibody

    15 Sep 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250915935641/en/Biocytogen-Announces-ADC-Innovator-Tubulis-Has-Signed-Global-Exclusive-License-Agreement-for-Single-Antibody

    BUSINESSWIRE
    15 Sep 2025
    Share Share
    Biocytogen Partners with Merck KGaA to Enhance For ADC Solution
    Biocytogen Partners with Merck KGaA to Enhance For ADC Solution

    03 Sep 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250903434045/en/Biocytogen-Enters-into-Agreement-with-Merck-KGaA-Darmstadt-Germany-to-Advance-Antibody-Conjugated-Lipid-Based-Delivery-Solutions

    BUSINESSWIRE
    03 Sep 2025
    Share Share
    Biocytogen Upgrades Preclinical Platform, Website Launch
    Biocytogen Upgrades Preclinical Platform, Website Launch

    28 Jul 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250728835434/en/Biocytogen-Upgrades-Preclinical-Service-Platform-and-Launches-Revamped-Global-Website

    BUSINESSWIRE
    28 Jul 2025
    Share Share
    Biocytogen, BeOne Ink Antibody Licensing Deal
    Biocytogen, BeOne Ink Antibody Licensing Deal

    09 Jul 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250709188805/en/Biocytogen-Enters-into-Antibody-Licensing-Agreement-with-BeOne-Medicines-to-Accelerate-Innovative-Drug-Development

    BUSINESSWIRE
    09 Jul 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search